6 matches across articles, videos and resources.
ArticleLab studies explore how methylene blue interacts with light and cancer cell energy use. Human evidence is thin, and the drug-interaction risks are serious.
ArticleA meta-analysis of small randomized trials linked melatonin to better tumor response and one-year survival, but later blinded trials did not confirm the benefit.
ArticleMethylene blue is approved for one blood condition and studied in cancer cells and mice. No human trial shows it treats cancer, and it interacts with common medicines.
ArticleDr. Johnston ranks the ten supplements and repurposed generic drugs he would put on his own shortlist, weighing human trials first, then animal and laboratory research.
ArticleDr. Johnston looks at studies linking obesity to cancer and examines whether GLP-1 medications are associated with lower cancer risk, noting that the evidence is observational.
ArticleDr. Johnston looks at what studies in animals and people report about gut bacteria, probiotics and the response to cancer immunotherapy.